WALTHAM, Mass.–(BUSINESS WIRE)–The Board of Administrators of Revvity, Inc. (NYSE: RVTY), at this time declared an everyday quarterly dividend of $0.07 per share of widespread inventory. This dividend is payable on February 7, 2025 to all shareholders of document on the shut of enterprise on January 17, 2025.
About Revvity
At Revvity, unattainable is inspiration, and cannot be executed is a name to motion. Revvity supplies well being science options, applied sciences, experience and providers that ship full workflows from discovery to growth, and analysis to treatment. Revvity is revolutionizing what’s attainable in healthcare, with specialised focus areas in translational multi-omics applied sciences, biomarker identification, imaging, prediction, screening, detection and analysis, informatics and extra.
With 2023 income of greater than $2.7 billion and over 11,000 workers, Revvity serves prospects throughout pharmaceutical and biotech, diagnostic labs, academia and governments. It’s a part of the S&P 500 index and has prospects in additional than 190 international locations.
Keep up to date by following our Newsroom, LinkedIn, X, YouTube, Fb (NASDAQ:) and Instagram.
View supply model on businesswire.com: https://www.businesswire.com/information/house/20241024806358/en/
Media Relations:
Chet Murray
(781) 462-5126
chet.murray@revvity.com
Investor Relations:
Steve Willoughby
steve.willoughby@revvity.com
Supply: Revvity
